LLY vs. ABBV
Compare and contrast key facts about Eli Lilly and Company (LLY) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LLY or ABBV.
Correlation
The correlation between LLY and ABBV is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
LLY vs. ABBV - Performance Comparison
Loading data...
Key characteristics
LLY:
-0.11
ABBV:
0.71
LLY:
0.08
ABBV:
0.97
LLY:
1.01
ABBV:
1.15
LLY:
-0.20
ABBV:
0.85
LLY:
-0.40
ABBV:
2.09
LLY:
12.45%
ABBV:
8.49%
LLY:
38.01%
ABBV:
27.46%
LLY:
-68.27%
ABBV:
-45.09%
LLY:
-23.23%
ABBV:
-14.01%
Fundamentals
LLY:
$659.45B
ABBV:
$326.55B
LLY:
$12.27
ABBV:
$2.34
LLY:
59.87
ABBV:
78.89
LLY:
1.16
ABBV:
0.39
LLY:
13.46
ABBV:
5.69
LLY:
44.23
ABBV:
229.63
LLY:
$49.00B
ABBV:
$57.37B
LLY:
$40.03B
ABBV:
$44.44B
LLY:
$16.67B
ABBV:
$16.33B
Returns By Period
In the year-to-date period, LLY achieves a -4.68% return, which is significantly lower than ABBV's 5.83% return. Over the past 10 years, LLY has outperformed ABBV with an annualized return of 28.33%, while ABBV has yielded a comparatively lower 15.61% annualized return.
LLY
-4.68%
0.29%
-11.36%
-2.72%
37.88%
28.33%
ABBV
5.83%
6.43%
-5.73%
19.02%
20.25%
15.61%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LLY vs. ABBV — Risk-Adjusted Performance Rank
LLY
ABBV
LLY vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
LLY vs. ABBV - Dividend Comparison
LLY's dividend yield for the trailing twelve months is around 0.74%, less than ABBV's 3.46% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 0.74% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% |
ABBV AbbVie Inc. | 3.46% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
LLY vs. ABBV - Drawdown Comparison
The maximum LLY drawdown since its inception was -68.27%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for LLY and ABBV. For additional features, visit the drawdowns tool.
Loading data...
Volatility
LLY vs. ABBV - Volatility Comparison
Eli Lilly and Company (LLY) has a higher volatility of 22.18% compared to AbbVie Inc. (ABBV) at 9.90%. This indicates that LLY's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
LLY vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Eli Lilly and Company and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LLY vs. ABBV - Profitability Comparison
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.